Fundraising Fox

Julie Yang

Investor

Vice President, Project and Portfolio Analytics at Third Rock Ventures

East Coast

About

Julie Yang, PhD, is VP of Project and Portfolio Analytics at Third Rock Ventures, joining in 2026 after investment roles at TCG Crossover, Leaps by Bayer, and Bain Capital Life Sciences, plus earlier work as a scientist at Dicerna Pharmaceuticals. She holds a PhD in molecular biology from Weill Cornell and an MBA from INSEAD.

Invests in

BiotechDigital HealthMedical Devices

Experience

  1. Third Rock VenturesVice Presidentcurrent2026 β€” presentBoston, Massachusetts, United States
  2. TCGXPrincipal2024 β€” 2026Boston, Massachusetts, United States
  3. Leaps by BayerSenior Director, Venture Investments2023 β€” 2024Cambridge, Massachusetts, United States
  4. Bain CapitalVice President2022 β€” 2023Greater Boston
  5. Bain CapitalAssociate2019 β€” 2021Greater Boston Area
  6. Qiming Venture Partners USAMohamed Chaoui Venture Fellow2019Cambridge, Massachusetts
  7. BayerAlliances Management Intern2018Greater New York City Area
  8. Alacrita ConsultingConsultant Analyst2017Cambridge, MA
  9. Dicerna Pharmaceuticals, Inc.Scientist II2014 β€” 2017Cambridge, MA
  10. Harvard Medical SchoolResearch Fellow2014Greater Boston Area
  11. New England Wildlife CenterIntern2013South Weymouth, MA
  12. Memorial Sloan-Kettering Cancer CenterResearcher2008 β€” 2013
  13. Weill Cornell Medical CollegeGraduate Student2007 β€” 2013New York, New York

Skills & more

Molecular Biology20Cell Culture14Molecular Cloning12Western Blotting18Cell Biology12Protein Expression5Transfection3Tissue Culture3RNA biology2Proteomics2Confocal Microscopy4Flow Cytometry6
+12 moreImmunofluorescenceCancerMass SpectrometryBiochemistryLife SciencesBiotechnologyBusiness StrategyValuationMicrosoft OfficeMicrosoft ExcelPharmaceuticsConsulting

Languages Chinese Β· English Β· French Β· German

From Julie's professional profile.

Colleagues at Third Rock Ventures

Frequently asked questions

Who is Julie Yang?
Julie Yang, PhD, is VP of Project and Portfolio Analytics at Third Rock Ventures, joining in 2026 after investment roles at TCG Crossover, Leaps by Bayer, and Bain Capital Life Sciences, plus earlier work as a scientist at Dicerna Pharmaceuticals. She holds a PhD in molecular biology from Weill Cornell and an MBA from INSEAD.
Where does Julie Yang work?
Julie Yang is Vice President, Project and Portfolio Analytics at Third Rock Ventures.
What does Julie Yang invest in?
Julie Yang invests in Biotech, Digital Health, Medical Devices.
Where did Julie Yang go to school?
Julie Yang studied at Joan & Sanford I. Weill Medical College of Cornell University (Doctor of Philosophy - PhD, Biochemistry/Molecular Biology/Genetics); INSEAD (Master of Business Administration - MBA); National Taiwan University (BS, Biochemical Science and Technology).

Same school

Shared employers